Heart failure hope? roxadustat tested for anemia and kidney disease

NCT ID NCT07268807

Not yet recruiting Disease control Sponsor: Zhongda Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether roxadustat, a drug for anemia in chronic kidney disease, can also help people with heart failure. Researchers will review medical records of 200 patients who took roxadustat for at least a year. They will check heart function, symptoms, and major events like hospitalizations or death.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: roxadustat
What this could lead to: If successful, this could show that roxadustat helps manage heart failure and anemia in people with chronic kidney disease, potentially improving their heart function and quality of life.
What could go wrong: This is a small, retrospective study that looks back at past data, not a controlled trial. Results may not prove cause and effect, and the drug may not work as hoped in larger, future studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia chronic kidney disease heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA CKD HEART FAILURE

Contacts and locations

Locations

Zhongda hospital Southeast University

Nanjing, Jiangsu, 210000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.